PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity

Area of Science:

• Bioconjugation Chemistry
• Protein Engineering
• Drug Development

Background:

• Chemical conjugation is vital for improving protein therapeutics but often causes non-specific modifications and loss of bioactivity.
• Existing methods lack precision, leading to suboptimal drug properties and potential side effects.

Purpose of the Study:

• To develop a versatile and widely applicable method for N-terminal specific protein modification.
• To generate site-specific protein bio-conjugates with high yield, purity, and retained bioactivity.

Main Methods:

• Utilized a combination of reversible side-chain blocking and protease-mediated cleavage of a HIS tag.
• Employed amine-reactive NHS ester chemistry for selective modification of the N-terminus.
• Validated N-terminal selectivity and specificity using mass spectral analyses.

Main Results:

• Achieved exquisite N-terminal specific modification of proteins with high yield and purity.
• Demonstrated near-complete retention of biological activity for the model protein (TNF-α) in vitro and in vivo.
• Confirmed site-specificity and selectivity through mass spectrometry.

Conclusions:

• The developed methodology enables precise N-terminal modification of proteins, overcoming limitations of current conjugation techniques.
• This approach is broadly applicable to various therapeutic proteins, facilitating the rapid generation of novel biologics with enhanced properties.
• The high specificity and bioactivity retention offer a significant advancement in protein therapeutic development.